Medtronic Plc [MDT] stock is trading at $98.33, down -0.10%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MDT shares have gain 3.24% over the last week, with a monthly amount glided 5.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on June 30, 2025, when Wolfe Research upgraded its rating to a Peer Perform. Previously, Leerink Partners started tracking the stock with Outperform rating on June 16, 2025, and set its price target to $110. On March 04, 2025, upgrade upgraded it’s rating to Buy and revised its price target to $107 on the stock. RBC Capital Mkts upgraded its rating to a Outperform and increased its price target to $105 on October 10, 2024. Oppenheimer reiterated its recommendation of a Perform and raised its price target to $94 on August 21, 2024. UBS upgraded its rating to Neutral for this stock on August 15, 2024, and upped its price target to $90. In a note dated August 14, 2024, Stifel downgraded an Hold rating on this stock and revised its target price from $100 to $85.
Medtronic Plc [MDT] stock has fluctuated between $79.29 and $98.66 over the past year. Currently, Wall Street analysts expect the stock to reach $115 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $98.33 at the most recent close of the market. An investor can expect a potential return of 16.95% based on the average MDT price forecast.
Analyzing the MDT fundamentals
Medtronic Plc [NYSE:MDT] reported sales of 34.20B for the trailing twelve months, which represents a growth of 8.38%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.1 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 97.70 points at the first support level, and at 97.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 99.17, and for the 2nd resistance point, it is at 100.00.
Ratios To Look Out For
For context, Medtronic Plc’s Current Ratio is 2.01. Also, the Quick Ratio is 1.50, while the Cash Ratio stands at 0.11. Considering the valuation of this stock, the price to sales ratio is 3.69, the price to book ratio is 2.63 and price to earnings (TTM) ratio is 27.15.
Transactions by insiders
Recent insider trading involved KIIL HARRY SKIP, EVP & President Cardiovascular, that happened on Sep 03 ’25 when 8605.0 shares were sold. Officer, KIIL HARRY SKIP completed a deal on Sep 03 ’25 to buy 8605.0 shares. Meanwhile, Director Jellison William R bought 2500.0 shares on Aug 22 ’25.
